Predictors of Ventriculoperitoneal Shunt Failure in Children Undergoing Initial Placement or Revision

Dani O Gonzalez1, Justin B Mahida, Lindsey Asti

  • 1Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio, USA.

Pediatric Neurosurgery
|August 5, 2016
PubMed

Insights

Ventriculoperitoneal (VP) shunt revisions are more likely to fail within 30 days than initial placements. Factors like congenital hydrocephalus, cardiac issues, seizures, and neuromuscular disease influence VP shunt failure rates in children.

Area of Science:

  • Neurosurgery
  • Pediatric Surgery
  • Health Services Research

Background:

  • Ventriculoperitoneal (VP) shunts are primary treatments for hydrocephalus.
  • High complication and revision rates for VP shunts present significant patient and healthcare burdens.
  • Understanding factors predicting short-term VP shunt failure is crucial for improving outcomes.

Purpose of the Study:

  • To identify factors associated with 30-day VP shunt failure in pediatric patients.
  • To compare failure rates between initial VP shunt placements and revisions.

Main Methods:

  • Analysis of VP shunt placements from the 2012-2013 American College of Surgeons National Surgical Quality Improvement Program (NSQIP) Pediatric database.
  • Inclusion of both initial shunt placements and revision surgeries.
  • Statistical analysis to identify independent predictors of 30-day shunt failure.

Main Results:

  • VP shunt revision surgery had a significantly higher 30-day failure rate (14%) compared to initial placements (8%).
  • In the initial placement group, congenital hydrocephalus was linked to increased shunt failure.
  • In the revision group, cardiac risk factors, chronic seizures, and neuromuscular disease history were associated with shunt failure.

Conclusions:

  • Identifying specific risk factors for VP shunt failure can guide the development of targeted interventions.
  • Further refinement of neurosurgical variables within the NSQIP Pediatric database is needed to pinpoint modifiable risk factors.
  • Reducing VP shunt failure rates can alleviate patient and healthcare system burdens.
Abstract

Related Concept Videos